Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI

Respiratory Physiology and Neurobiology

Volumn 170, Issue 1, 2010, Pages 23-31

  Huertas, Alice ^a   Testa, Ugo ^b   Riccioni, Roberta ^b   Petrucci, Eleonora ^b   Riti, Viviana ^b   Savi, Daniela ^a   Serra, Pietro ^a   Bonsignore, Maria Rosaria ^c,d   Palange, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d CNR   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Fat free mass; Low BMI COPD; Normal BMI COPD

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; SCATTER FACTOR; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VASCULOTROPIN C;

AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; BONE MARROW DEPRESSION; CD34 SELECTION; CELL COUNT; CELL ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; LUNG FUNCTION TEST; NUTRITIONAL ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD; BLOOD CELL COUNT; BODY MASS INDEX; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; COLONY-FORMING UNITS ASSAY; CREATINE KINASE; CYTOKINES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LACTATE DEHYDROGENASES; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 74449084198     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2009.10.003     Document Type: Article

References (53)

1. Agustí A.G., Sauleda J., Miralles C., Gomez C., Togores B., Sala E., Batle S., and Busquets X. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 166 (2002) 485-489
2. Agustí A.G., Noguera A., Sauleda J., Sala E., Pons J., and Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 21 (2003) 347-360
3. Agustí A., Morlá M., Sauleda J., Saus C., and Busquets X. NF-kB activation and iNOS upregulation in skeletal muscle of patient with COPD and low body weight. Thorax 59 (2004) 483-487
4. Assmus B., Honold J., Schächinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., Teupe C., Pistorius K., Martin H., Abolmaali N.D., Tonn T., Dimmeler S., and Zeiher A.M. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355 (2006) 1222-1232
5. Baluk P., Tammela T., Ator E., Lyubynska N., Achen M.G., Hicklin D.J., Jeltsch M., Petrova T.V., Pytowski B., Stacker S.A., Ylä-Herttuala S., Jackson D.G., Alitalo K., and McDonald D.M. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115 (2005) 247-257
6. Bhandari V., Choo-Wing R., Lee C.G., Zhu Z., Nedrelow J.H., Chupp G.L., Zhang X., Matthay M.A., Ware L.B., Homer R.J., Lee P.J., Geick A., de Fougerolles A.R., and Elias J.A. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat. Med. 12 (2006) 1286-1293
7. Biskobing D.M. COPD and osteoporosis. Chest 121 (2002) 609-620
8. Blann A.D., and Pretorius A. Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins?. Atherosclerosis 188 (2006) 12-18
9. Bonsignore M.R., Morici G., Santoro A., Pagano M., Cascio L., Bonanno A., Abate P., Mirabella F., Profita M., Insalaco G., Gioia M., Vignola A.M., Majolino I., Testa U., and Hogg J.C. Circulating haematopoietic progenitor cells in runners. J. Appl. Physiol. 93 (2002) 1691-1697
10. Boschetto P., Miniati M., Miotto D., Braccioni F., De Rosa E., Bononi I., Papi A., Saetta M., Fabbri L.M., and Mapp C.E. Predominant emphysema phenotype in chronic obstructive pulmonary. Eur. Respir. J. 21 (2003) 450-454
11. Broekhuizen R., Wouters E.F., Creutzberg E.C., and Schols A.M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61 (2006) 17-22
12. Burrows B., Fletcher C.M., Heard B.E., Jones N.L., and Wootliff J.S. The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. Lancet 1 (1966) 830-835
13. Bussolino F., Di Renzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., and Comoglio P.M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119 (1992) 629-641
14. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., Pinto Plata V., and Cabral H.J. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350 (2004) 1005-1012
15. Charbonneau M., Harper K., Grondin F., Pelmus M., McDonald P.P., and Dubois C.M. Hypoxia-inducible factor mediates hypoxic and TNF alpha-induced increases in TACE/ADAM17 expression by synovial cells. J. Biol. Chem. 282 (2007) 33714-33724
16. Durnin J.V.G.A., and Womersley J. Body fat assessed from total body density and its estimation from skin fold thickness: measurements on 481 men and women aged from 16 to 72 years. Br. J. Nutr. 32 (1974) 77-97
17. Fadini G.P., Avogaro A., and Agostini C. Critical assessment of putative endothelial progenitor phenotypes. Exp. Haematol. 35 (2009) 1479-1480
18. Fadini G.P., Schiavoni M., Cantini M., Baesso I., Facco M., Miorin M., Tassinato M., Vigili de Kreutzenberg S., Avogaro A., and Agostini C. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 24 (2006) 1806-1813
19. Fiedler U., and Augustin H.G. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 27 (2006) 552-558
20. Fiedler U., Reiss Y., Scharpfenecker M., Grunow V., Koidl S., Thurston G., Gale N.W., Witzenrath M., Rosseau S., Suttorp N., Sobke A., Herrmann M., Preissner K.T., Vajkoczy P., and Augustin H.G. Angiopoietin-2 sensizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation. Nat. Med. 12 (2006) 235-239
21. Gan W.Q., Man S.F., Senthilselvan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59 (2004) 574-580
22. Garrod R., Marshall J., Barley E., Fredericks S., and Hagan G. The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). Prim. Care Respir. J. 16 (2007) 236-240
23. Global Strategy for the Diagnosis. Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006 (2006)
24. Guddo F., Vignola A.M., Saetta M., Baraldo S., Siena L., Balestro E., Zuin R., Papi A., Maestrelli P., Fabbri L.M., Bonsignore G., and Turato G. Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis. Eur. Respir. J. 27 (2006) 957-963
25. Hellwig-Bürgel T., Rutkowski K., Metzen E., Fandrey J., and Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94 (1999) 1561-1567
26. Hoffman R., Tong J., Brandt J., Traycoff C., Bruno E., McGuire B.W., Gordon M.S., McNiece I., and Srour E.F. The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Stem Cells 11 Suppl. 2 (1993) 76-82
27. Huang M.S., Tsai M.S., Wang T.H., Chong I.W., Hou J.J., Lin Y.J., and Hwang J.J. Serum hepatocytes growth factor levels in patients with inflammatory lung diseases. Kaoshiung J. Med. Sci. 15 (1999) 195-201
28. Ince H., Petzsch M., Kleine H.D., Schmidt H., Rehders T., Körber T., Schümichen C., Freund M., and Nienaber C.A. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112 (2005) 3097-3106
29. Kang H.J., Lee H.Y., Na S.H., Chang S.A., Park K.W., Kim H.K., Kim S.Y., Chang H.J., Lee W., Kang W.J., Koo B.K., Kim Y.J., Lee D.S., Sohn D.W., Han K.S., Oh B.H., Park Y.B., and Kim H.S. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114 Suppl. 1 (2006) I145-I151
30. Kranenburg A.R., Willems-Widyastuti A., Mooi W.J., Saxena P.R., Sterk P.J., de Boer W.I., and Sharma H.S. Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-I. J. Pathol. 206 (2005) 28-38
31. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., and Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
32. LaBarge M.A., and Blau H.M. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111 (2002) 589-601
33. Langen R.C., Schols A.M., Kelders M.C., van der Velden J.L., Wouters E.F., and Janssen-Heininger Y.M. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am. J. Respir. Cell Mol. Biol. 35 (2006) 689-696
34. Mukae H., Vincent R., Quinlan K., English D., Hards J., Hogg J.C., and van Eeden S.F. The effect of repeated exposure to particulate air pollution (PM10) on the bone marrow. Am. J. Respir. Crit. Care Med. 163 (2001) 201-209
35. Nowak G., Karrar A., Holmen C., Nava S., Uzunel M., Hultenby K., and Sumitran-Holgersson S. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelization. Circulation 110 (2004) 3699-3707
36. O'Donnell D.E., and Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur. Respir. Rev. 15 (2006) 61-67
37. Otrock Z.K., Makarem J.A., and Shamseddine A.I. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol. Dis. 38 (2007) 258-268
38. Palange P., Forte S., Felli A., Galassetti P., Serra P., and Carlone S. Nutritional state and exercise tolerance in patients with COPD. Chest 107 (1995) 1206-1212
39. Palange P., Forte S., Onorati P., Paravati V., Manfredi F., Serra P., and Carlone S. Effect of reduced body weight on muscle aerobic capacity in patients with COPD. Chest 114 (1998) 12-18
40. Palange P., Forte S., Onorati P., Manfredi F., Serra P., and Carlone S. Ventilatory and metabolic adaptation to walking end cycling in patients with COPD. J. Appl. Physiol. 88 (2000) 1715-1720
41. Palange P., Testa U., Huertas A., Calabrò L., Antonucci R., Petrucci E., Pelosi E., Pasquini L., Satta A., Morici G., Vignola M.A., and Bonsignore M.R. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur. Respir. J. 27 (2006) 529-541
42. Pinto-Plata V.M., Livnat G., Girish M., Cabral H., Masdin P., Linacre P., Dew R., Kenney L., and Celli B.R. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 131 (2007) 37-43
43. Sandau K.B., Zhou J., Kietzmann T., and Brüne B. Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276 (2001) 39805-39811
44. Schols A.M., Slangen J., Volovics L., and Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157 (1998) 1791-1797
45. Sin D.D., and Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107 (2003) 1514-1519
46. Sin D.D., and Man S.F. Skeletal muscle weakness, reduced exercise tolerance and COPD: is systemic inflammation the missing link?. Thorax 61 (2006) 1-3
47. + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110 (2004) 1209-1212
48. van Eeden S.F., and Hogg J.G. The response of human bone marrow to chronic cigarette smoking. Eur. Respir. J. 15 (2000) 915-921
49. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89 (2001) E1-E7
50. Virag J.A., Rolle M.L., Reece J., Hardouin S., Feigl E.O., and Murry C.E. Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am. J. Pathol. 171 (2007) 1431-1434
51. Walter R.E., Wilk J.B., Larson M.G., Vasan R.S., Keaney Jr. J.F., Lipinska I., O'connor G.T., and Benjamin E.J. Systemic inflammation and COPD: the Framingham Heart Study. Chest 133 (2008) 19-25
52. Wouters E.F., Creutzberg E.C., and Schols A.M. Systemic effects in COPD. Chest 121 (2002) 127S-130S
53. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., Krasich R., Temm C.J., Prchal J.T., and Ingram D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809